Here, we focus solely on structure-activity relationships (SAR) for different chemical series and their effect on tau of FTD iPSC-derived neurons to identify degraders that promote tau and P-tau reduction in a disease context. The gene discussed is MAPT; the disease is frontotemporal dementia.